LINN Energy and LinnCo to Suspend Dividend
July 30, 2015
The Dividend Cushion has foretold another cut! On July 30, along with second-quarter results, LINN Energy (LINE) announced it will recommend the suspension of payment of LINN Energy’s distribution and LinnCo’s dividend at the end of the third quarter of 2015 in order to save ~$450 million in cash from the annualized payouts. LINN Energy reported a net loss in both quarters thus far in 2015, and its yield was near 15%; simply unsustainable. We’ve been warning our readers about the risks associated with LINN Energy and LinnCo (LNCO) and their high-yielding payouts for over two years now, as we did again earlier this month. We rated the entity’s distribution safety as VERY POOR, based on its Dividend Cushion ratio
The Story of Chemical Giants: Sales Down, Margins Up
July 30, 2015
Chemical bellwethers’ second-quarter results reflect the impact of unfavorable commodity prices and demand, but cost cutting efforts and savvy execution are driving margins higher. Let’s go around the horn for incremental industry insights across the space. Dow Chemical is executing the best at the moment. DuPont (DD), Dow Chemical (DOW), and Eastman Chemical (EMN) all reported negative impacts from pricing on their top lines in the calendar second period. DuPont’s Performance Chemicals segment, which was spun-off into The Chemours Company (CC) on July 1, reported the largest negative impact for the company with pricing lowering sales by 6% in the period. Each of Dow Chemical’s operating segments experienced sales falling due to pricing, the largest of which came in its
Kinder Morgan’s Shares Still Not Cheap, Dividend Financially-Engineered
July 30, 2015
Kinder Morgan released its 10-Q for the second quarter of 2015 on July 24. The Corporation’s Dividend Continues to Be Financially-Engineered The second-quarter 10-Q revealed that, through the first six months of 2015, free cash flow of ~$630 million, which consists of $2.54 billion in cash flow from operations less $1.91 billion in total capital expenditures, came up significantly short against the company’s total cash dividend outlays of $2 billion during the same six-month period. Said differently, traditional non-GAAP free cash flow less cash dividends paid has been -$1.37 billion, negative $1.37 billion, during the first six months of the year. During the first half of 2015, the company issued $2.56 billion in new shares and floated net debt of
Annual US Defense Spending Still 85% Higher Than Year of September 11 Attacks
July 29, 2015
July 8 brought news that the Army plans to cut 40,000 troops over the next two years in a decision that will impact command posts across the globe. By the end of 2017, the Army plans to have 450,000 soldiers, down from levels of 570,000 at the peak of the Iraq/Afghanistan wars and the lowest number of active US Army soldiers since the beginning of World War II. The 450,000 mark is widely believed to be the level at which, if it falls below, the US may not be able to effectively meet defense strategies. Bare minimum, it would seem. But while personnel cuts are being implemented, geopolitical uncertainty has only increased. The Islamic State of Iraq and the Levant
Altria Outperforms; Smoking Marlboros Back on the Rise?
July 29, 2015
We’ve pounded the table time and time again on Altria (MO), even including it in both the Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio. The company has been one of our favorite corporate dividend payers, and its large equity stake in SABMiller (SBMRY) offers it financial flexibility like few others. We thought shares have been undervalued for some time, but in the mid-$50s each at present, we’re looking to trim our position. We may use the release of the August edition of the Dividend Growth Newsletter to do so. Altria has a ~4% dividend yield and boasts a 1.2 Dividend Cushion ratio. Fundamentally speaking, things could not be better for Altria. Second-quarter net revenue advanced nearly 6%, to
Railroads Reveal Economic Concerns in the US
July 29, 2015
Valuentum wrote a comprehensive outlook on the coal industry and railroads in this July 2013 piece here, and to a very large degree, the piece couldn’t have told the future better. Not only did we warn against the most heavily-leveraged coal producers, including James River, Arch Coal (ACI) and Walter Energy, but we threw cold water on the entire coal industry altogether. James River and Walter Energy subsequently filed for bankruptcy. We pointed to economic and political pressures making coal a less viable utility option in the US, as we stated that heightened competition in the US export market would make met coal a less attractive proposition. Since the publishing of the piece, coal operators have suffered immensely. The Market
3 Reasons Why Buffalo Wild Wings Is a Long-Term Winner
July 29, 2015
#1: Buffalo Wild Wings Has Captured the Hearts of Children “Plant the Brownie acorn and the Kodak oak will grow.” George Eastman knew all too well about winning the hearts of children. The inventor-entrepreneur popularized flexible film in the 1880s, and his first Kodak camera was available for purchase by the end of the decade. But the breakthrough was too expensive, and it wasn’t until the Kodak Brownie, released a dozen years later, that photography was democratized. The camera sold for just a $1 and was easy to use. But importantly, Eastman focused his marketing and advertising efforts on children. When these children grew up, the seeds had been planted, and Eastman had built an empire. The Kodak oak grew.
Quick Take: Gilead Blows By 2Q Estimates; Investors Getting Drug Pipeline for Free
July 28, 2015
Gilead (GILD) has delivered. The company’s second-quarter 2015 results showed product sales of $8.1 billion and non-GAAP earnings per share of $3.15, up 27% and 33%, respectively, from the same period a year ago. For those that don’t know Gilead, the company’s hepatitis C powerhouse drug, Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg), led to the quarterly outperformance. We continue to believe the market is 1) underestimating the sustainability of Harvoni (both the number of potential patients to be treated globally and pricing resiliency) as well as its drug development pipeline, which we believe investors are getting for free. Gilead is a holding in the portfolio of the Best Ideas Newsletter, and we don’t expect to make any changes following the
You Didn’t Miss This Best Ideas Newsletter Email Alert, Did You?
July 28, 2015
Let’s take a look at this email alert from July 24, 2013. What would be the returns two years hence? Note: Intuitive Surgical had subsequently been removed from the portfolio. Apple and Union Pacific have engaged in stock splits since the email alert. To read a full audit of the Best Ideas Newsletter portfolio, please click here.
Best Ideas Newsletter Holding Teva Surges!
July 28, 2015
On July 27, Teva Pharmaceuticals (TEVA) reported solid preliminary results for the second quarter of 2015. The firm is growing organically, and its fundamental strengths shone throughout its report. Revenue increased 6% in the period, after excluding the impact of currency headwinds and the sale of US OTC plants in the second quarter of 2014. Non-GAAP operating income grew 16% from the year-ago quarter to $1.6 billion, and non-GAAP earnings per share increased 15% to $1.43 in the period. Cash flow from operations advanced an impressive 41% to $1.5 billion in the second quarter, and free cash flow grew 51% to $1.3 billion in the period. The solid bottom line performance caused management to raise its earnings per share guidance
